157 related articles for article (PubMed ID: 20799356)
1. Editorial: Canadian mass spectrometry: applications in medical research.
Boyd B; Bohme D
Mass Spectrom Rev; 2010; 29(6):861. PubMed ID: 20799356
[No Abstract] [Full Text] [Related]
2. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies.
Walsh GM; Rogalski JC; Klockenbusch C; Kast J
Expert Rev Mol Med; 2010 Sep; 12():e30. PubMed ID: 20860882
[TBL] [Abstract][Full Text] [Related]
3. In praise of toolmakers.
Fenselau C
J Proteome Res; 2009 May; 8(5):2135. PubMed ID: 19309079
[No Abstract] [Full Text] [Related]
4. Mass spectrometry: from proteomics to metabolomics and lipidomics.
Griffiths WJ; Wang Y
Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
[TBL] [Abstract][Full Text] [Related]
5. Editorial for "advances in biological mass spectrometry and proteomics".
Cramer R
Methods; 2011 Aug; 54(4):349-50. PubMed ID: 21839395
[No Abstract] [Full Text] [Related]
6. Crosslinking combined with mass spectrometry for structural proteomics.
Petrotchenko EV; Borchers CH
Mass Spectrom Rev; 2010; 29(6):862-76. PubMed ID: 20730915
[TBL] [Abstract][Full Text] [Related]
7. Proteomics: the new frontier also for brain tumor research.
Chumbalkar V; Sawaya R; Bogler O
Curr Probl Cancer; 2008; 32(3):143-54. PubMed ID: 18501776
[No Abstract] [Full Text] [Related]
8. Mass spectrometry in systems biology: an overview.
Feng X; Liu X; Luo Q; Liu BF
Mass Spectrom Rev; 2008; 27(6):635-60. PubMed ID: 18636545
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry: m/z 1983-2008.
Zhou M; Veenstra T
Biotechniques; 2008 Apr; 44(5):667-8, 670. PubMed ID: 18474043
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
Zhan X; Desiderio DM
Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometers for the analysis of biomolecules.
Baldwin MA
Methods Enzymol; 2005; 402():3-48. PubMed ID: 16401505
[TBL] [Abstract][Full Text] [Related]
13. New developments in proteomics.
Massing MW; Misiurek J; Chadaram SR; Marx CE; Madison R
N C Med J; 2007; 68(2):119-22. PubMed ID: 17566558
[No Abstract] [Full Text] [Related]
14. The future of biological mass spectrometry.
Vestal ML
J Am Soc Mass Spectrom; 2011 Jun; 22(6):953-9. PubMed ID: 21953036
[TBL] [Abstract][Full Text] [Related]
15. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
[TBL] [Abstract][Full Text] [Related]
17. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
Liu X; Wen F; Yang J; Chen L; Wei YQ
Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
[TBL] [Abstract][Full Text] [Related]
18. Highlight report: high-resolution mass spectrometry.
Blaszkewicz M
Arch Toxicol; 2016 Dec; 90(12):3149-3150. PubMed ID: 27815600
[No Abstract] [Full Text] [Related]
19. Targeted metabolomics for biomarker discovery.
Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and metabolomics and their application to analgesia research.
Reisdorph NA; Reisdorph R
Methods Mol Biol; 2010; 617():457-73. PubMed ID: 20336441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
